Armando Ferraretti

Armando Ferraretti

Auto-generated profile, based on publicly available information

Armando Ferraretti

Department of Medical & Surgical Sciences, University of Foggia, Foggia, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2014 in Clinical Cardiology
Verified
Journal Article
Closed access
PDF file
Francesco SantoroFrancesco Santoro
Francesco Santoro
RIRiccardo Ieva
Riccardo Ieva
FMFrancesco Musaico
Francesco Musaico
AFArmando Ferraretti
Armando Ferraretti
GTGiuseppe Triggiani
Giuseppe Triggiani
NBNatale Daniele Brunetti
Natale Daniele Brunetti

27 November 2013 in Cardiovascular Therapeutics
Verified
Journal Article
Closed access
PDF file
Francesco SantoroFrancesco Santoro
Francesco Santoro
RIRiccardo Ieva
Riccardo Ieva
AFArmando Ferraretti
Armando Ferraretti
VIVincenzo Ienco
Vincenzo Ienco
GCGiuseppe Carpagnano
Giuseppe Carpagnano
NBNatale Daniele Brunetti
Natale Daniele Brunetti

18 May 2016 in Cardiovascular Therapeutics
Verified
Journal Article
Closed access
PDF file
Francesco SantoroFrancesco Santoro
Francesco Santoro
RIRiccardo Ieva
Riccardo Ieva
AFArmando Ferraretti
Armando Ferraretti
MFMario Fanelli
Mario Fanelli
FMFrancesco Musaico
Francesco Musaico
NBNatale Daniele Brunetti
Natale Daniele Brunetti

1 November 2016 in Atherosclerosis
Verified
Journal Article
Closed access
Francesco SantoroFrancesco Santoro
Francesco Santoro
NTNicola Tarantino
Nicola Tarantino
AFArmando Ferraretti
Armando Ferraretti
RIRiccardo Ieva
Riccardo Ieva
FMFrancesco Musaico
Francesco Musaico
NBNatale Daniele Brunetti
Natale Daniele Brunetti

1 October 2018 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
MCMichele Correale
Michele Correale
AFArmando Ferraretti
Armando Ferraretti
IMIlenia Monaco
Ilenia Monaco
DGDavide Grazioli
Davide Grazioli
MBMatteo Di Biase
Matteo Di Biase
NBNatale Daniele Brunetti
Natale Daniele Brunetti
Pulmonary arterial hypertension, a disease largely neglected until a few decades ago, is presently the object of intense studies by several research teams. Despite considerable progress, pulmonary arterial hypertension remains a major clinical problem, because it is not always easy to diagnose, treat, and prevent. The disease was considered incurable until the late 1990s, when Epoprostenol was introduced as the first tool against this illness. More recently, therapy for pulmonary arterial hypertension gained momentum after publication of the SERAPHIN and AMBITION trials, which also highlighted the importance of upfront therapy. This review also focuses on recent substudies from these trials and progress in drugs targeting the endothelin pathway. Future perspectives with regard to endothelin-receptor antagonists are also discussed.

1 July 2018 in Atherosclerosis
Verified
Journal Article
Closed access
Francesco SantoroFrancesco Santoro
Francesco Santoro
MCMaria Domenica Costantino
Maria Domenica Costantino
FGFrancesca Guastafierro
Francesca Guastafierro
GTGiuseppe Triggiani
Giuseppe Triggiani
AFArmando Ferraretti
Armando Ferraretti
NBNatale Daniele Brunetti
Natale Daniele Brunetti